Movers and Shakers Today 5 Stocks Making Wild Moves

 Top.Gainers
 
  Top.Gainers
 
Follow  Message
 
 
 
Top.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
 

•  31 Oct 2025
 

•   ATGE  
   
  +2.89%
•   BENF  
   
  +2.47%
•   BFLY  
   
  -1.82%
•   CABA  
   
  +2.85%
•   CURR  
   
  +6.48%

$BENF rocketed 48.24% higher to $0.83 after the Nasdaq Hearings Panel notified Beneficient that the company had successfully regained compliance with two critical listing requirements. For a stock facing potential delisting, this represents a significant reprieve that removed a major overhang weighing on sentiment. Volume exploded to over 135 million shares compared to an average of just 37 million, suggesting genuine conviction behind the buying as traders who had been sitting on the sidelines rushed back in.

$CABA captured attention with a robust 46.15% gain to $3.61, propelled by encouraging clinical trial data. Cabaletta Bio announced positive results for its Rese-cel candidate across myositis, systemic sclerosis, and systemic lupus erythematosus trials. For biotech investors, positive clinical data represents the holy grail of catalysts, as it validates the scientific thesis underlying the company's entire pipeline. Volume surged to over 35 million shares versus a typical 4.37 million, indicating the market is taking these results seriously and potentially repricing the stock based on improved probabilities of eventual FDA approval.

$MNOV delivered the most explosive move, with a regular-session gain of 39.5% to $1.66 after an 87% after-hours surge the previous evening. MediciNova announced breakthrough research findings that immediately captured the attention of biotech speculators. What makes this move particularly noteworthy is the volume explosion of 47 million shares against an average of just 223,000, representing more than 200 times normal activity. This kind of surge suggests news spread rapidly across trading desks and social media, creating a feedback loop of buying pressure.

$BFLY demonstrated that beating estimates can reignite investor interest, with shares climbing 31.54% to $2.69. Butterfly Network reported a non-GAAP loss of $0.04 per share, beating expectations by a penny, while revenues of $21.5 million topped forecasts. The company's focus on AI-powered ultrasound technology positions it at the intersection of two market-favorite themes: artificial intelligence and healthcare innovation. Management's commentary around new AI tools and chip advances fueled optimism about the path toward profitability.

$CURR rounded out the gainers with a 30.8% advance to $3.78, marking five consecutive sessions of gains. While no specific catalyst was apparent, technical traders pay attention to persistent uptrends as they can signal accumulation by informed buyers with visibility into upcoming developments.

On the downside,
$ATGE crashed 30.86% to $98.02 as Adtalem Global Education faced sector-wide pressure in education and training services stocks. The magnitude of the decline far exceeded the sector's 3.1% drop, suggesting fundamental concerns beyond simple technical selling. $INTS delivered the session's most dramatic reversal, plummeting 44.72% to $0.73 after an extraordinary 395% surge the previous day. This classic boom-and-bust scenario reminds traders that parabolic moves rarely hold their gains for long. $RUBI extended its losing streak to seven consecutive sessions with a 45.81% decline to $0.78, while $FLUX dropped 35.25% on its sixth straight down day and $VVPR plunged 35.02% following a Form 13G filing.

View All Headlines